---
title: Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy
  response in pancreatic cancer
date: '2025-01-06'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39762215/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250107170841&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Pancreatic ductal adenocarcinoma (PDAC) displays a high degree of spatial
  subtype heterogeneity and co-existence, linked to a diverse microenvironment and
  worse clinical outcome. However, the underlying mechanisms remain unclear. Here,
  by combining preclinical models, multi-center clinical, transcriptomic, proteomic,
  and patient bioimaging data, we identify an interplay between neoplastic intrinsic
  AP1 transcription factor dichotomy and extrinsic macrophages driving subtype co-existence
  and ...
disable_comments: true
---
Pancreatic ductal adenocarcinoma (PDAC) displays a high degree of spatial subtype heterogeneity and co-existence, linked to a diverse microenvironment and worse clinical outcome. However, the underlying mechanisms remain unclear. Here, by combining preclinical models, multi-center clinical, transcriptomic, proteomic, and patient bioimaging data, we identify an interplay between neoplastic intrinsic AP1 transcription factor dichotomy and extrinsic macrophages driving subtype co-existence and ...